Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: Comparison of the methods

Journal of Alzheimer's Disease

Volumn 44, Issue 1, 2015, Pages 329-338

  Zimny, Anna ^a   Bladowska, Joanna ^a   Macioszek, Adam ^b   Szewczyk, Paweł ^a   Trypka, Elzbieta ^a   Wojtynska, Renata ^a   Noga, Leszek ^a   Leszek, Jerzy ^a   Sasiadek, Marek ^a,c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b 4TH MILITARY HOSPITAL   (Poland)

^c Euromedic Wroclaw PET CT Medical Center   (Poland)

Author keywords

Amnestic mild cognitive impairment; Diffusion tensor imaging; Glucose metabolism; Magnetic resonance spectroscopy; Perfusion weighted imaging; Positron emission tomography; Posterior cingulate gyrus

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOBUTROL; GLUCOSE;

AGED; ARTICLE; BRAIN BLOOD VOLUME; BRAIN SCINTISCANNING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLITE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; AMNESIA; ANISOTROPY; CASE CONTROL STUDY; CINGULATE GYRUS; COMPARATIVE STUDY; COMPLICATION; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCINTIGRAPHY; SCINTISCANNING;

AGED; AMNESIA; ANISOTROPY; CASE-CONTROL STUDIES; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84920764122     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132138     Document Type: Article

References (32)

1. Petersen RC, Doody R, Kurz A, Mohs JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58, 1985-1992.
2. Nestor PJ, Fryer TD, Smielewski P, Hodges JR (2003) Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann Neurol 54, 343-351.
3. Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M (2011). Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: Value of magnetic resonance spectroscopy, perfusion and diffusion tensor imaging of the posterior cingulate region. J Alzheimers Dis 27, 591-601.
4. Desgranges B, Baron JC, de la Sayette V, Petit-Taboue MC, Benali K, Landeau B, Lechevalier B, Eustache F (1998) The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 121, 611-631.
5. Silverman DHS, Gambhir SS, HuangHW, Schwimmer J, Kim S, SmallGW, Chodosh J, Czernin J, PhelpsME(2002) Evaluating early dementia with and without assessment of regional cerebral metabolism by PET:Acomparison of predicted costs and benefits. J Nucl Med 43, 253-266.
6. Mosconi L, Tsui WH, Herholtz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien- Baumann B, Kurz A, Minoshima S, de Leon MJ (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease and other dementias. J Nucl Med 49, 390-398.
7. Berti V, Pupi A, Mosconi L (2011) PET/CT in diagnosis of dementia. Ann NY Acad Sci 1228, 81-92.
8. Bohnen NI, Djang DSW, Herholtz K, Anzai Y, Minoshima S (2012) Effectiveness of safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature. J Nucl Med 53, 59-71.
9. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D (2005) Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 62, 1728-1733.
10. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang- Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR, Jr. (2004) 1H MRspectroscopy in common dementias. Neurology 63, 1393-1398.
11. Wang Z, Zhao C, Yu L, Zhou W, Li K (2009) Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer's disease. Acta Radiol 50, 312-319.
12. Zimny A, Szewczyk P, Czarnecka A, Trypka E, Wojtynska R, Leszek J, Sasiadek M (2010) Usefulness of perfusion-weighted MR imaging in the differential diagnosis of Alzheimer's disease and mild cognitive impairment. Med Sci Mon 16(Suppl 1), 5-10.
13. Zimny A, Szewczyk P, Bladowska J, Trypka E, Wojtynska R, Leszek J, Sasiadek M (2012) Quantitative evaluation of changes in the selected white matter tracts using diffusion tensor imaging in patients with Alzheimer's disease and mild cognitive impairment. Neuroradiol J 25, 300-310.
14. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW (2007) Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer's disease. Neurology 68, 13-19.
15. Parente DB, Gasparetto EL, da Cruz LC, Jr., Domingues RC, Baptista AC, Carvalho AC, Domingues RC (2008) Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease. Am J Roentgenol 190, 1369-1374.
16. Chua TC, WenW, Chen X, Kochan N, Slavin MJ, Trollor JN, Brodaty H, Sachdev PS (2009) Diffusion tensor imaging of the posterior cingulate is useful biomarker of mild cognitive impairment. Am J Geriatr Psychiatry 17, 602-613.
17. McKhann GM, Knopman DS, Chertkow H, Hyman B, Jack CR, Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
18. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
19. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
20. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PC, Mori S (2004) Fiber tract-based atlas of human white matter anatomy. Radiology 230, 77-87.
21. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ (1990) Functional cerebral imaging by susceptibilitycontrast NMR. Magn Reson Med 14, 538-546.
22. Talairach J, Tournoux P (1988) Co-Planar Stereotaxic Atlas of the Human Brain: 3-D Proportional System: An Approach to Cerebral Imaging, Thieme Medical Press, New York.
23. Soonawala D, Amin T, Ebmeier KP, Steele JD, Dougall NJ, Best J, Migneco O, Nobili F, Scheidhauer K (2002) Statistical parametric mapping of 99mTc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: Normalizing to cerebellar tracer uptake. Neuroimage 17, 1193-2202.
24. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine- 18-FDG PET. J Nucl Med 36, 1238-1248.
25. Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ (2010) Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis 20, 843-854.
26. Lambert LF, Barlow AK, Chromy BA (1998) Diffusible, nonfibrillar ligands derived from Abeta 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453.
27. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155, 853-862.
28. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001) Diffusion tensor imaging: Concepts and applications. J Magn Reson Imaging 13, 534-546.
29. Taylor WD, Hsu E, Krishnan KR, MacFall JR (2004) Diffusion tensor imaging: Background, potential, and utility in psychiatric research. Biol Psychiatry 55, 201-207.
30. Selnes P, Aarsland D, Bjomerud A, Gjerstad L, Wallin A, Hessen E, Reinvang I, Grambaite R, Auning E, Kjervik VK, Due-Tonnessen P, StensetV, Fladby T (2013) Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimers Dis 33, 723-736.
31. Cavallin L, Axelsson R, Wahlund LO, Oksengard AR, Svensson L, Juhlin P, Wiberg MK, Frank A (2008) Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease. Acta Radiol 49, 1154-1161.
32. Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, KimbergDY, WolkDA, Julin P, Newberg AB, Arnold SE, Detre JA (2012) Direct comparison of FDG-PET and ASL-MRI in Alzheimer's disease. Alzheimers Dement 8, 51-59.